Enhancing Physical Activity Levels of Frail Older People With a Wearable Activity Tracker-based Exercise Intervention

April 7, 2020 updated by: Dr. Justina Liu Yat Wa, The Hong Kong Polytechnic University

Enhancing the Physical Activity Levels of Community-dwelling Older People With Frailty Through an Exercise Intervention With or Without a Wearable Activity Tracker (WAT)-Based Intervention: a Feasibility and Pilot Study

This study aims to investigate the feasibility, acceptability, and preliminary effects of a Wearable Activity Tracker (WAT)-based exercise intervention to increase physical activity levels in frail or pre-frail older people. One group of participants will receive a WAT-based exercise intervention incorporated with the support of behavioral change techniques (BCTs) and technical issues, while the other group will receive only an exercise intervention incorporated with BCTs support.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Six community centres, which provide similar types of community care and social support services for community-dwelling older people, will be invited by a convenience method to work as collaborators in this study. Using computer-generated random numbers, a biostatistician not affiliated with this study will randomize the centres in a 1:1 ratio into either: the control or the experimental groups (WAT group).

The WAT group will receive a 3-month exercise programme plus WAT intervention which aims to strengthen the participants' motivation to develop the intention to gradually increase their physical activity levels to eventually meet the level recommended for older people by the American Heart Association (AHA). Two face-to-face sessions followed by weekly to monthly telephone sessions offering support on dealing with technical issues and BCTs will be arranged for the experimental group. The additional technical support given alongside the WAT intervention will be gradually withdrawn from the participants. Eventually, all additional measures to support the use of WATs among participants will be stopped. Participants will be left to use the WAT on their own for 3 months during the follow-up period. In addition, they will receive a weekly 45-60 minute center-based structured exercise programme for 3 months, which is designed according to the AHA's recommendations on exercise for older people.

The control group will receive another 3-month exercise programme with face-to-face, and telephone-delivered BCTs follow-up sessions, with the number and timing of all sessions similar to that in the experimental group.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, Hong Kong
        • The Hong Kong Polytechnic Universtiy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • community-dwelling older people aged > 65 years;
  • able to communicate in Cantonese to ensure that they understand our instructions;
  • able to walk with or without an assistive device and able to complete the Time Up and Go (TUG) test with no specific cutoff point to ensure that their mobility and balance is good enough to join the exercise training;
  • able to use a smartphone;
  • with daily walking steps less than 7000, and
  • in a pre-frail or frail state as determined using the Fried Frailty Index; including: i) having experienced an unintentional loss of 10% of body weight in the past year; ii) exhaustion: by answering 'Yes' to either 'I felt that everything I did was an effort', or 'I could not get going in the last week'; iii) a slow walk time: with an average walking speed in the lowest quintile stratified by median body height; iv) reduced grip strength: with maximal grip strength in the lowest quintile stratified by the body mass index quartile; and v) a Physical Activity Scale for Elderly-Chinese (PASE-C) score in the lowest quartile (i.e., < 30 for men and < 27.7 for women). The presence of 1-2 indicates pre-frailty, > 3 items indicates frailty.

Exclusion Criteria are older people who:

  • have any physical conditions that hamper their performance of the exercise programme or use of the WAT, such as visual or hearing problems.
  • regularly engage in moderately intense exercise (such as hiking, Tai Chi) for > 3 hours per week.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: WAT group
The WAT group will receive a 3-month WAT-based exercise training programme, which includes 12 weekly exercise training sessions (an hour each) in addition to 2 face-to-face sessions followed by weekly to monthly telephone sessions offering support on dealing with technical issues and BCTs (7 session in total). The WAT group will be left to use the WAT on their own for 3 months during the follow-up period.
The WAT intervention consists of 12 weekly WAT-based exercise sessions and 7 sessions of support for BCTs and technical issues.
No Intervention: Control group
The control group will receive a 3-month exercise training programme without a WAT, which also includes 12 weekly exercise training sessions (an hour each) in addition to 7 face-to-face and telephone sessions offering support for BCTs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of using the activity tracker
Time Frame: Throughout the 3-month programme
The number of days that a participant in the experimental group wears and syncs the device divided by the number of intervention days.
Throughout the 3-month programme
Recruitment rate
Time Frame: Enrollment date
The proportion of participants who consent to join the study over the eligible participants.
Enrollment date
Attrition rate
Time Frame: At the end of the 3-month programme
The percentage of participants who withdraw from the study and their reasons for withdrawing.
At the end of the 3-month programme
Adherence to the exercise regimen
Time Frame: Throughout the 3-month programme
Exercise adherence will be assessed by the training session attendance, the participants' adherence to the desired levels of MVAP as suggested by the physical trainer and the exercise diary.
Throughout the 3-month programme
Occurrence of adverse events at home
Time Frame: Throughout the 3-month programme
Any adverse events at home will be recorded.
Throughout the 3-month programme
Change of activity levels (total steps) measured by ActiGraph wGT3X accelerometer.
Time Frame: Change from Baseline Activity Level at 1 week, *1 month and * 3 month post-intervention (* only for the experimental group)
The participants' total steps will be collected.
Change from Baseline Activity Level at 1 week, *1 month and * 3 month post-intervention (* only for the experimental group)
Change of activity levels (activity) measured by ActiGraph wGT3X accelerometer.
Time Frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention(* only for the experimental group)
The time spent in activities of different intensity (sedentary, light, moderate and vigorous) will be collected.
Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention(* only for the experimental group)
Change of sleep quality (sleep time) measured by ActiGraph wGT3X accelerometer.
Time Frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention. (* only for the experimental group)
The participant's total sleep time will be collected.
Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention. (* only for the experimental group)
Change of sleep quality (wake after sleep onset) measured by ActiGraph wGT3X accelerometer.
Time Frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention.(* only for the experimental group)
The frequency of wake after sleep onset of the participant will be collected.
Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention.(* only for the experimental group)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activity levels (total steps) assessed by activity monitor (Fitbit)
Time Frame: Throughout the 3-month programme
The total steps per week of an individual will be collected.
Throughout the 3-month programme
Activity levels (total walking distance) assessed by activity monitor (Fitbit)
Time Frame: Throughout the 3-month programme
The total walking distance per week of an individual will be collected.
Throughout the 3-month programme
Activity levels (time spent in different heart rate zones) assessed by activity monitor (Fitbit)
Time Frame: Throughout the 3-month programme
The time spent in different heart rate zones of an individual will be collected.
Throughout the 3-month programme
Participants' lower-limb strength will be assessed using the 30-second chair stand test
Time Frame: Baseline, at 1 week, *1 month and* 3 month post-intervention (* only for the experimental group)
Participants will be asked to stand up and sit down as many as they can within 30 seconds on a standard chair. The total number of standing up from a chair will be counted. More number indicates better lower-limb strength
Baseline, at 1 week, *1 month and* 3 month post-intervention (* only for the experimental group)
Participants' upper-limb strength will be assessed using a handheld Jamar Hydraulic Hand Dynamometer
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
It will be measured by handheld Jamar Hydraulic Hand Dynamometer with kilogram (kg). Greater force in kg indicates better upper-limb strength
Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
Participants' functional mobility will be measured by the timed-up-and-go-test
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention
Record the time in second that participants complete the timed up and go test to indicate their functional mobility
Baseline, at 1 week, *1 month and *3 month post-intervention
Participants' gait speed will be measured by the 2 minutes walk test
Time Frame: Baseline, at 1 week, 1 month and 3 month post-intervention (* only for the experimental group)
Record the time in second that participants complete the 2 minutes walk test to indicate the their gait speed.
Baseline, at 1 week, 1 month and 3 month post-intervention (* only for the experimental group)
Participants' exercise self-efficacy will be measured using Chinese Self-Efficacy for Exercise (CSEE) scale
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
The CSEE scale contains of 9 items. Each item is rated on 11-point Liker scale from 0 = no confidence to 10 = full of confidence. All item scores are summed to get the total score which ranges from 0 to 90 with a higher score indicates higher exercise self-efficacy
Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
Participants' frailty level will be assessed using Fried Frailty Index (FFI)
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
Fried Frailty Index includes: i) an unintentional loss of 10% of body weight in the past year; ii) exhaustion: by answering 'Yes' to either 'I felt that everything I did was an effort', or 'I could not get going in the last week'; iii) a slow walk time: with an average walking speed in the lowest quintile stratified by median body height; iv) reduced handgrip strength: with maximal grip strength in the lowest quintile stratified by body mass index quartile; and v) the Physical Activity Scale for the Elderly-Chinese (PASE-C) score in the lowest quintile (i.e., < 30 for men and < 27.7 for women).
Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
Participants' self-reported sedentary behavioral and physical activity will be assessed using Global Physical Activity Questionnaire-Chinese version (C-GPAQ)
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
The C-PAQ comprises 16 questions designed to estimate an individual's self-perceived level of physical activity in three domains (occupational, transport-related and discretionary or leisure time).
Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
Participants' motivation to engage in physical activity using of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2)
Time Frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)
C-BREQ-2 is a 19-item questionnaire assessing five dimensions: amotivation, external regulation, introjected regulation, identified regulation, and intrinsic regulation. Each item is rated on a 5-point scale ranging from 0 = "not true for me" to 4 = "very true for me", with higher scores indicative of higher motivation.
Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Justina LIU, Dr., The Hong Kong Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

March 31, 2020

Study Completion (Actual)

March 31, 2020

Study Registration Dates

First Submitted

April 19, 2018

First Submitted That Met QC Criteria

May 24, 2018

First Posted (Actual)

May 29, 2018

Study Record Updates

Last Update Posted (Actual)

April 9, 2020

Last Update Submitted That Met QC Criteria

April 7, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HSEARS20180320006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly

Clinical Trials on WAT

Subscribe